logo

For the Inventor, By the Inventor

Düsseldorf, Germany

Wolfgang Greb

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Henkel Ag & Company, Kgaa. Active years: 1978-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Greb. Retrieved from https://idiyas.com/inventor/wolfgang-greb-zcurlb5v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Dusseldorf, DE (1978 - 1979)
  • Duesseldorf, DE (1985)
  • Duesseldorf-Kaiserswerth, DE (1986)

Company Filing History:

goldMedal4 out of 4,541 
 
Henkel Ag & Company, Kgaa
 patents

Years Active: 1978-1986

Loading Chart...
4 patents (USPTO):Explore Patents
1. 4608368 - 1-hydroxy-1,1-diphosphonic acids and cytostatic use thereof (1986-08-26),
2. 4537771 - Antacids containing zeolitic molecular sieves (1985-08-27),
3. 4133872 - Compositions for preparation of aqueous solutions of salts of lower (1979-01-09),
4. 4104366 - Compositions for preparation of aqueous solutions of low valence .sup.99 (1978-08-01),

Title: Wolfgang Greb: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang Greb is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 4 patents, Greb has focused on developing compounds that address various medical conditions.

Latest Patents

Among his latest patents, Greb has developed 1-hydroxy-1,1-diphosphonic acids and their cytostatic uses. These compounds correspond to a specific general formula where R and R1 can represent either hydrogen or methyl. Additionally, he has created antacids containing zeolitic molecular sieves. These antacids utilize zeolitic sodium aluminosilicates and/or potassium aluminosilicates of the A, X, Y, or P type molecular sieves, combined with pharmaceutical adjuvant material. Such antacids are particularly useful in treating gastric hyperacidity and related conditions.

Career Highlights

Greb has had a distinguished career, working with prominent companies such as Henkel Kommanditgesellschaft Auf Aktien. His work has significantly impacted the pharmaceutical industry, showcasing his expertise in developing innovative solutions for health-related issues.

Collaborations

Throughout his career, Wolfgang Greb has collaborated with notable colleagues, including Manfred Schmidt-Dunker and Helmut Blum. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Wolfgang Greb's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to innovation and improving healthcare solutions. His work continues to influence the industry and offers valuable advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…